NASDAQ · RCGTX · USD
Stock price, dividends
Quote as of Oct 30, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Virtus Zevenbergen Technology Fund CL C’s quoted price sits in the upper half of its reported 52-week range, 12.26% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Virtus Zevenbergen Technology Fund CL C’s forward annual dividend is $7.58 per share, paid annual. The forward yield is 45.46% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
This fund's primary objective is to generate significant capital appreciation over the long term. To achieve this, it typically allocates a minimum of 80% of its total assets (including any leveraged capital for investment purposes) to common stocks and other ownership stakes in technology sector companies. It may also utilize financial derivatives and other complex instruments that exhibit similar economic characteristics to technology equities. Notably, this fund maintains a non-diversified investment approach.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 11:36 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$19.46-$0.55 (-2.75%)
Allspring Diversified Capital Builder Fund Class A’s quoted price sits in the upper half of its reported 52-week range, 6.98% below the high.
$22.37-$0.38 (-1.67%)
NYLI MacKay Convertible Fund;I’s quoted price sits in the upper half of its reported 52-week range, 7.18% below the high.
$22.29-$0.38 (-1.68%)
NYLI MacKay Convertible Fund Investor Class’s quoted price sits in the upper half of its reported 52-week range, 7.09% below the high.
$15.27-$0.03 (-0.2%)
Allspring Diversified Capital Builder Fund Administrator Class’s quoted price sits in the upper half of its reported 52-week range, 0.2% below the high.
$46.56-$2.34 (-4.79%)
BlackRock Science and Technology Trust’s quoted price sits in the upper half of its reported 52-week range, 11.01% below the high.
$51.92-$0.43 (-0.82%)
Gabelli Asset Fund (The)’s quoted price sits in the upper half of its reported 52-week range, 4.21% below the high.
$26.51-$0.46 (-1.71%)
Columbia Cornerstone Equity Fund Institutional 2 Class’s quoted price sits in the upper half of its reported 52-week range, 3.53% below the high.
$40.93-$0.44 (-1.06%)
ClearBridge Mid Cap Fund Class I’s quoted price sits in the upper half of its reported 52-week range, 5.14% below the high.
